In conclusion, the positive correlation found between Clusterin and the most atherogenic components of lipid profile (total cholesterol and LDL), highlights the importance that this protein can have in modulating the lipid balance of an individual especially during aging where visible changes in the lipid parameters occur, and in cardiovascular diseases where the absolute risk associated with dyslipidemia rises with advancing age [45]. Here, CLU is linked to metabolic syndrome.